IDEXX LABORATORIES INC /DE Foreign Currency Contract, Asset, Fair Value Disclosure
IDEXX LABORATORIES INC /DE (IDXX) had Foreign Currency Contract, Asset, Fair Value Disclosure of $7.99 million as of 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Notes › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:ForeignCurrencyContractAssetFairValueDisclosure · last filed 2023-11-01
- 2023-09-30: Foreign Currency Contract, Asset, Fair Value Disclosure $7.99M.
- 2023-06-30: Foreign Currency Contract, Asset, Fair Value Disclosure $3.92M.
- 2023-03-31: Foreign Currency Contract, Asset, Fair Value Disclosure $4.31M.
- 2022-12-31: Foreign Currency Contract, Asset, Fair Value Disclosure $5.18M.
| Period end | Foreign Currency Contract, Asset, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $7.99M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $3.92M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $4.31M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $5.18M 10-Q · filed 2023-11-01 |
| 2022-09-30 | $22.33M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $14.86M 10-Q · filed 2022-08-02 |
| 2021-12-31 | $6.51M 10-K · filed 2023-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |